重庆市基本药物集中采购政策对药品价格的影响机制研究

发布时间：2018-12-10 12:08

【摘要】：目的:研究重庆市以药品交易所(以下简称药交所)为平台的基本药物集中采购政策对药品价格的影响,为完善我国药品集中采购政策提出建议。方法:列表比较重庆市以药交所为平台实施集中采购基本药物政策前后的基本药物价格,并将采用世界卫生组织/国际健康行动机构标准调查法获得的价格数据与国际参考价格进行比较。结果:重庆市实施药交所平台集中采购基本药物后,除小部分低价基本药物价格较实施前有所升高外,大部分基本药物的价格均降低,但是总体上基本药物的价格仍要高于国际参考价格。结论:通过制定入市价、挂牌价、成交价的价格约束机制,重庆市基本药物价格逐渐趋于合理,但与国际参考价格仍有一定差距。建议进一步构建科学的基本药物采购价格形成机制,扩大药交所规模效益,提高市场集中度和配送效率,加强药品价格和配送监管,以保障基本药物的可及性。
[Abstract]:Objective: to study the influence of the centralized purchasing policy of essential drugs on the drug price in Chongqing on the platform of Drug Exchange (hereinafter referred to as Drug Exchange), and to put forward some suggestions for perfecting the centralized purchasing policy of drugs in China. Methods: the prices of essential drugs in Chongqing before and after the centralized purchase of essential drugs were compared. The price data obtained by the WHO / IHA standard survey method are compared with the international reference prices. Results: after centralized purchasing of essential drugs on the platform of Chongqing Institute of Drug Exchange, the prices of most essential drugs decreased, except that the prices of a small number of low-cost essential drugs were higher than those before implementation. But on the whole, the price of essential drugs is still higher than the international reference price. Conclusion: the price of essential drugs in Chongqing tends to be reasonable, but there is still a certain gap between the price of essential drugs and the international reference price. It is suggested that we should further construct a scientific price formation mechanism for essential drugs, expand the scale benefit of drug exchange, improve market concentration and distribution efficiency, strengthen drug price and distribution supervision, so as to ensure the availability of essential drugs.
【作者单位】：北京协和医学院;中国医学科学院医学信息研究所/卫生政策与管理研究中心;
【分类号】：R95

【参考文献】